Related Experiment Video
Updated: Sep 2, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Fungal infections: Pathogenesis, antifungals and alternate treatment approaches
G Kiran Kumar Reddy1,2, Alwar Ramanujam Padmavathi1, Y V Nancharaiah1,2
1Biofouling and Biofilm Processes Section, Water and Steam Chemistry Division, Chemistry Group, Bhabha Atomic Research Centre, Kalpakkam 603 102, Tamil Nadu, India.
Abstract:
Increasing incidence of fungal infections of recent times requires immediate intervention. Fungal infections are seldom construed at initial stages that intensify the severity of infections and complicate the treatment procedures. Fungal pathogens employ various mechanisms to evade the host immune system and to progress the severity of infections. For the treatment of diverse superficial and systemic infections, antifungal drugs from the available repertoire are administered. However, well documented evidence of fungal resistance to most of the antifungal drugs hampers disease control and poses challenges in antifungal therapy. Several physiological adaptations and genetic mutations followed by their selection in presence of antifungal agents drive the resistance development in fungi. The availability of limited antifungal arsenal, emergence of resistance and biofilm-conferred resistance drives the need for development of novel drugs and alternate approaches for the better treatment outcome against mycoses. This graphical review explicitly shed light on various fungal infections and causative organisms, pathogenesis, different antifungal drugs and resistance mechanisms including host immune response and evasion strategies. Here, we have highlighted recent developments on novel antifungal agents and other alternate approaches for fighting against fungal infections.
Insights
Fungal infections are rising, and drug resistance complicates treatment. New antifungal drugs and alternative strategies are crucial for combating these challenging mycoses.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Drug Discovery
Background:
- Fungal infections are increasingly prevalent and often diagnosed late, worsening outcomes.
- Fungal pathogens possess mechanisms to evade host immunity, increasing infection severity.
- Existing antifungal drugs face significant resistance, hindering effective treatment.
Purpose of the Study:
- To review current knowledge on fungal infections, pathogenesis, and antifungal drug resistance.
- To highlight novel antifungal agents and alternative therapeutic strategies.
- To provide insights into host immune responses and fungal evasion tactics.
Main Methods:
- Graphical review of fungal infections and causative agents.
- Analysis of antifungal drug mechanisms and resistance pathways.
- Compilation of recent advancements in antifungal drug development and alternative therapies.
Main Results:
- Fungal resistance, including biofilm-associated resistance, is a major therapeutic challenge.
- Limited antifungal arsenal necessitates the development of new treatment modalities.
- Host immune evasion strategies contribute to fungal pathogenesis.
Conclusions:
- Novel antifungal agents and alternative approaches are urgently needed to overcome resistance and improve treatment outcomes for mycoses.
- Understanding fungal pathogenesis and host-pathogen interactions is key to developing effective therapies.
- This review synthesizes current research on combating challenging fungal infections.
Related Concept Videos
Fungal Phylum Microsporidia
Overview of Fungi
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Fungal Phylum Basidiomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

